BoneGrafix, Inc., a Rockville, Md.-based medical device and biomaterials company whose products replace missing or diseased bone and effect healing and remodeling of bone tissue, has received an investment of undisclosed amount from Global Biotech Corp (OTCBB: GBIQ) (CNSX: GBQ).
The company intends to use the funds to support the commercialization of its synthetic bone products.
With the investment, Global Biotech Corp will take a minority stake in BoneGrafix.
Led by Chairman and CEO Dr. George Steinfels, the company is developing a product portfolio focused on purely synthetic bone products (implants) that are designed to enable new bone formation and reduce the need for invasive harvesting procedures that are currently used.
FinSMEs
04/03/2011